Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.

<h4>Objective</h4>A high level of cerebrospinal fluid (CSF) neopterin is a marker of central nervous system inflammatory-immune mediated processes. We aimed to assess data from 606 neuropediatric patients, describing the clinical and biochemical features of those neurological disorders p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Molero-Luis, Sergio Fernández-Ureña, Iolanda Jordán, Mercedes Serrano, Aida Ormazábal, Àngels Garcia-Cazorla, Rafael Artuch, Neopterin Working Group
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/071d2a441a7944f2a72b805dfeb839f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:071d2a441a7944f2a72b805dfeb839f6
record_format dspace
spelling oai:doaj.org-article:071d2a441a7944f2a72b805dfeb839f62021-11-18T08:41:18ZCerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.1932-620310.1371/journal.pone.0083237https://doaj.org/article/071d2a441a7944f2a72b805dfeb839f62013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24367586/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>A high level of cerebrospinal fluid (CSF) neopterin is a marker of central nervous system inflammatory-immune mediated processes. We aimed to assess data from 606 neuropediatric patients, describing the clinical and biochemical features of those neurological disorders presenting CSF neopterin values above a new cut-off value that was defined in our laboratory.<h4>Methods</h4>To establish the new CSF neopterin cut-off value, we studied two groups of patients: Group 1 comprised 68 patients with meningoencephalitis, and Group 2 comprised 52 children with a confirmed peripheral infection and no central nervous system involvement. We studied 606 CSF samples from neuropediatric patients who were classified into 3 groups: genetic diagnosis (A), acquired/unknown etiologic neurologic diseases (B) and inflammatory-immune mediated processes (C).<h4>Results</h4>The CSF neopterin cut-off value was 61 nmol/L. Out of 606 cases, 56 presented a CSF neopterin level above this value. Group C had significantly higher CSF neopterin, protein and leukocyte values than the other groups. Sixteen of twenty-three patients in this group had a CSF neopterin level above the cut-off, whereas three and seven patients presented increased leukocyte and protein values, respectively. A significant association was found among CSF neopterin, proteins and leukocytes in the 606 patients. White matter disturbances were associated with high CSF neopterin concentrations.<h4>Conclusions</h4>Although children with inflammatory-immune mediated processes presented higher CSF neopterin values, patients with other neurological disorders also showed increased CSF neopterin concentrations. These results stress the importance of CSF neopterin analysis for the identification of inflammatory-immune mediated processes.Marta Molero-LuisSergio Fernández-UreñaIolanda JordánMercedes SerranoAida OrmazábalÀngels Garcia-CazorlaRafael ArtuchNeopterin Working GroupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e83237 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marta Molero-Luis
Sergio Fernández-Ureña
Iolanda Jordán
Mercedes Serrano
Aida Ormazábal
Àngels Garcia-Cazorla
Rafael Artuch
Neopterin Working Group
Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
description <h4>Objective</h4>A high level of cerebrospinal fluid (CSF) neopterin is a marker of central nervous system inflammatory-immune mediated processes. We aimed to assess data from 606 neuropediatric patients, describing the clinical and biochemical features of those neurological disorders presenting CSF neopterin values above a new cut-off value that was defined in our laboratory.<h4>Methods</h4>To establish the new CSF neopterin cut-off value, we studied two groups of patients: Group 1 comprised 68 patients with meningoencephalitis, and Group 2 comprised 52 children with a confirmed peripheral infection and no central nervous system involvement. We studied 606 CSF samples from neuropediatric patients who were classified into 3 groups: genetic diagnosis (A), acquired/unknown etiologic neurologic diseases (B) and inflammatory-immune mediated processes (C).<h4>Results</h4>The CSF neopterin cut-off value was 61 nmol/L. Out of 606 cases, 56 presented a CSF neopterin level above this value. Group C had significantly higher CSF neopterin, protein and leukocyte values than the other groups. Sixteen of twenty-three patients in this group had a CSF neopterin level above the cut-off, whereas three and seven patients presented increased leukocyte and protein values, respectively. A significant association was found among CSF neopterin, proteins and leukocytes in the 606 patients. White matter disturbances were associated with high CSF neopterin concentrations.<h4>Conclusions</h4>Although children with inflammatory-immune mediated processes presented higher CSF neopterin values, patients with other neurological disorders also showed increased CSF neopterin concentrations. These results stress the importance of CSF neopterin analysis for the identification of inflammatory-immune mediated processes.
format article
author Marta Molero-Luis
Sergio Fernández-Ureña
Iolanda Jordán
Mercedes Serrano
Aida Ormazábal
Àngels Garcia-Cazorla
Rafael Artuch
Neopterin Working Group
author_facet Marta Molero-Luis
Sergio Fernández-Ureña
Iolanda Jordán
Mercedes Serrano
Aida Ormazábal
Àngels Garcia-Cazorla
Rafael Artuch
Neopterin Working Group
author_sort Marta Molero-Luis
title Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
title_short Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
title_full Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
title_fullStr Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
title_full_unstemmed Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
title_sort cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/071d2a441a7944f2a72b805dfeb839f6
work_keys_str_mv AT martamoleroluis cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT sergiofernandezurena cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT iolandajordan cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT mercedesserrano cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT aidaormazabal cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT angelsgarciacazorla cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT rafaelartuch cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
AT neopterinworkinggroup cerebrospinalfluidneopterinanalysisinneuropediatricpatientsestablishmentofanewcutoffvaluefortheidentificationofinflammatoryimmunemediatedprocesses
_version_ 1718421424040837120